Skip to search formSkip to main contentSkip to account menu

GVAX prostate cancer vaccine

Known as: GM-CSF prostate cancer vaccine, allogeneic prostate cancer vaccine, GM-CSF gene transduced, GVAX Allogeneic Prostate Cancer Vaccine 
A whole cell vaccine expressing human granulocyte macrophage-colony stimulating factor (GM-CSF) with potential antineoplastic activity. Tumor cells… 
National Institutes of Health

Related topics

Related topics

2 relations
Granulocyte-Macrophage Colony-Stimulating FactorNCIt Antineoplastic Agent Terminology

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2014
Highly Cited
2014
A phase 2 study of allogeneic mesenchymal stromal cells for luminal Crohn's disease refractory to biologic therapy.
Highly Cited
2012
Highly Cited
2012
Combined immunotherapy with granulocyte-macrophage colony-stimulating factor-transduced allogeneic prostate cancer cells and ipilimumab in patients with metastatic castration-resistant prostate…
Highly Cited
2005
Highly Cited
2005
Boosting antitumor responses of T lymphocytes infiltrating human prostate cancers
Immunotherapy may provide valid alternative therapy for patients with hormone-refractory metastatic prostate cancer. However, if… 
Review
2004
Review
2004
Mesenchymal stem cells and their potential as cardiac therapeutics.
Mesenchymal stem cells (MSCs) represent a stem cell population present in adult tissues that can be isolated, expanded in culture… 
Highly Cited
2003
Highly Cited
2003
Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation
Background. Marrow stromal cells (MSC) can differentiate into multiple mesenchymal tissues. To assess the feasibility of human… 
Highly Cited
1997
Highly Cited
1997
Total body irradiation and acute graft-versus-host disease: the role of gastrointestinal damage and inflammatory cytokines.
The influence of bone marrow transplantation (BMT) conditioning regimens on the incidence and severity of graft-versus-host… 
Highly Cited
1994
Highly Cited
1994
Administration of recombinant IL-12 to normal mice enhances cytolytic lymphocyte activity and induces production of IFN-gamma in vivo.
IL-12 is a heterodimeric cytokine that has been shown to enhance natural killer (NK) and cytotoxic T lymphocyte (CTL) responses… 
Highly Cited
1988
Highly Cited
1988
Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppression.
An increase in the dose of chemotherapy enhances the response of many experimental and clinical cancers, but the extent of dose… 
Highly Cited
1987
Highly Cited
1987
The immunostimulatory effect of T cells and T cell lymphokines on murine fetally derived placental cells.
Evidence for maternal immune recognition of the fetus can be found during pregnancy, yet the conceptus remains unharmed. Indeed… 
Highly Cited
1969
Highly Cited
1969
Active immunotherapy for acute lymphoblastic leukaemia.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)